Home › Trial NCT05784012
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
- Trial IDNCT05784012
- StatusActive Not Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorGrupo Español de Tratamiento de Tumores de Cabeza y Cuello
- Enrollment34
- Start date2023-11-13
- ConditionsHead and Neck Squamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.